Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis. (2011)

First Author: Dickens JA
Attributed to:  Mechanisms of neurotoxicity of amyloid aggregates funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/dddt.s14018

PubMed Identifier: 21966212

Publication URI: http://europepmc.org/abstract/MED/21966212

Type: Journal Article/Review

Volume: 5

Parent Publication: Drug design, development and therapy

ISSN: 1177-8881